Cédric Van Marcke

13PUBLICATIONS
77CO-AUTHORS
PhysiotherapyMolecular targetsPredictive and prognostic markersCancer geneticsDeep learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 04, 2026
Beamion PANTUMOR-1: rationale and design of a Phase II trial of zongertinib in HER2-overexpressed/amplified or HER2-mutant solid tumors.

Alison M Schram, John J Park, Antoine Italiano

|Aug 11, 2025
Tumor-Informed ctDNA Assay to Predict Outcome in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated with PD-1 Inhibitor.

Natasha Honoré, George Laliotis, Vasily N Aushev

|May 06, 2025
The gut microbiome and cancer: from tumorigenesis to therapy.

Amandine Nobels, Cédric van Marcke, Bénédicte F Jordan

|Jan 31, 2025
PPARα-mediated lipid metabolism reprogramming supports anti-EGFR therapy resistance in head and neck squamous cell carcinoma.

Valentin Van den Bossche, Julie Vignau, Engy Vigneron

|Jan 09, 2024
A federated learning system for precision oncology in Europe: DigiONE.

Piers Mahon, Ismini Chatzitheofilou, Andre Dekker

Pageof 3